Authors
Levchuk A.L.1, Starokon P.M.2, Khodyrev S.A.3, Shabaev R.M.3, Shihmetov A.N.1
1 Pirogov National Medical and Surgical Center, Moscow
2 Philial of the Military Medical Academy named after S.M. Kirov, Moscow
3 Military medical organization, Golitsyno
Abstract
Currently, there is a tendency to an increase in the incidence of dyshormonal dysplasia of the mammary glands, characterized by a wide range of proliferative and regressive changes in breast tissue with a violation of the ratio of epithelial and connective tissue components. The most commonly used resection techniques for the treatment of fibrocystic disease with a predominance of the cystic component have their obvious drawbacks in the form of violations of the anatomical structure of breast tissue, pain in the early postoperative period, postoperative scars and deformities. Minimally invasive methods of treating fibrocystic disease allow you to avoid all the negative aspects, reduce the period of stay in the hospital. Their use is possible in the outpatient clinic.
The paper presents a retrospective analysis of the treatment of 334 patients with benign breast dysplasia with cyst formation. The patients were divided into 3 groups depending on the nature of the surgical interventions performed. For the first time, minimally invasive methods of treating fibrocystic disease with a predominance of the cystic component were used, in particular, sclerosing of cysts using a holmium laser, intracystic injection of 1% sodium tetradecyl sulfate solution. Evaluation of the quality of life of patients with fibrocystic disease in the long-term postoperative period was carried out using the Russian version of the questionnaire «MOS Short Form 36».
The use of minimally invasive methods of treating fibrocystic disease in 158 patients made it possible to eliminate aesthetic defects from the mammary glands, reduce the patients stay in the hospital, optimize drug therapy support, improve quality of life. The results obtained prove the effectiveness of minimally invasive surgical methods in the surgical treatment of women with benign breast dysplasia.
Keywords: fibrocystic disease, benign breast dysplasia, minimally invasive methods, laser coagulation, sclerotherapy, quality of life.
References
1. Bespalov VG, Travina ML. Fibrocystic disease and the risk of breast cancer (literature review). Tumors of the female reproductive system. 2015; 11(4): 58-70. (In Russ). doi: 10.17650/1994-4098-2015-11-4-58-70.
2. Onstad M, Stuckey A. Benign breast disorders. Obstet Gynecol Clin North Am. 2013; 40(3): 459-473.
3. Kaprin AD, Rozhkova NI Benign breast diseases. М.: GEOTAR-Media, 2019. (In Russ).
4. Chissov VI. Oncology — national leadership. М.: GEOTAR-Media, 2013. 1061 р. (In Russ).
5. Kerchelaeva SB, Smetnik AA, Bespalov VG. Mastopathy and prevention of breast cancer as an interdisciplinary problem. Mother and child. 2016; 24(15): 1018-1025. (In Russ).
6. Prilepskaya VN. The use of homeopathic medicines for the treatment of mastalgia and mastopathy. The attending Physician. 2012; 11: 1-4. (In Russ).
7. Putyrsky LA. Benign and malignant breast diseases. A manual for students and doctors. 2008. р.10-18. (In Russ).
8. Zotov AS., Belik EO. Mastopathy and breast cancer. М.: MEDpress-inform, 2005. 112 р. (In Russ).
9. Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med. 1994; 331(1): 10-15.
10. Nassar A, Visscher DW, Degnim AC, et al. Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study. Breast Cancer Res Treat. 2015; 153 (2): 397-405.
11. Khodyrev SA, Levchuk AL, Shabaev RM. Quality of life of patients after reconstructive breast surgery. Bulletin of the National Medical and Surgical Center named after N.I. Pirogov. 2022; 17(1): 58-63. (In Russ).
12. Starokon PM. Surgical treatment of fibrocystic mastopathy: modern trends. Bulletin of the Medical Institute “REAVIZ”. 2019; 4(40): 157-169. (In Russ).
13. Patent for invention № RU2669048C1/05.10.18. Byul. № 28 dated 19.10.2018. Shabaev R.M., Starokon P.M. Method of surgical treatment of breast cysts. (In Russ).
14. Maksimov IB, Starokon PM, Shabaev RM, Galik NI. Minimally invasive technologies of surgical treatment of precancerous disease — fibrocystic mastopathy. Long-term results. Materials of the XXIII Russian Oncological Congress, 2019. Р.107-108). (In Russ).
15. Rodionov VV, Smetnik AA. Benign diseases of the mammary glands. Obstetrics and gynecology: news, opinions, training. 2018; 1(19): 90-100. (In Russ).
16. Starokon PM, Shashkina MK. Studying the quality of life of patients with adhesive processes in the abdominal cavity. Educational and methodical manual. 2008. 80 р. (In Russ).
17. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30(6): 473-483.
